File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.ibiod.2006.05.002
- Scopus: eid_2-s2.0-33845972300
- WOS: WOS:000244017700002
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Mechanism of hexavalent chromium detoxification by microorganisms and bioremediation application potential: A review
Title | Mechanism of hexavalent chromium detoxification by microorganisms and bioremediation application potential: A review |
---|---|
Authors | |
Keywords | Bioremediation Chromium Detoxification Metal Reduction Proteomics |
Issue Date | 2007 |
Publisher | Elsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/ibiod |
Citation | International Biodeterioration And Biodegradation, 2007, v. 59 n. 1, p. 8-15 How to Cite? |
Abstract | Chromium has been widely used in various industries. Hexavalent chromium (Cr 6+) is a priority toxic, mutagenic and carcinogenic chemical, whereas its reduced trivalent form (Cr 3+) is much less toxic and insoluble. Hence, the basic process for chromium detoxification is the transformation of Cr 6+ to Cr 3+. A number of aerobic and anaerobic microorganisms are capable of reducing Cr 6+. In the presence of oxygen, microbial reduction of Cr 6+ is commonly catalyzed by soluble enzymes, except in Pseudomonas maltophilia O-2 and Bacillus megaterium TKW3, which utilize membrane-associated reductases. Recently, two soluble Cr 6+ reductases, ChrR and YieF, have been purified from Pseudomonas putida MK1 and Escherichia coli, respectively. ChrR catalyzes an initially one-electron shuttle followed by a two-electron transfer to Cr 6+, with the formation of intermediate(s) Cr 5+ and/or Cr 4+ before further reduction to Cr 3+. YieF displays a four-electron transfer that reduces Cr 6+ directly to Cr 3+. The membrane-associated Cr 6+ reductase of B. megaterium TKW3 was isolated, but its reduction kinetics is as yet uncharacterized. Under anaerobic conditions, both soluble and membrane-associated enzymes of the electron transfer system were reported to mediate Cr 6+ reduction as a fortuitous process coupled to the oxidation of an electron donor substrate. In this process, Cr 6+ serves as the terminal electron acceptor of an electron transfer chain that frequently involves cytochromes (e.g., b and c). An expanding array of Cr 6+ reductases allows the selection of enzymes with higher reductive activity, which genetic and/or protein engineering may further enhance their efficiencies. With the advancement in technology for enzyme immobilization, it is speculated that the direct application of Cr 6+ reductases may be a promising approach for bioremediation of Cr 6+ in a wide range of environments. © 2006. |
Persistent Identifier | http://hdl.handle.net/10722/178975 |
ISSN | 2023 Impact Factor: 4.1 2023 SCImago Journal Rankings: 0.990 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheung, KH | en_US |
dc.contributor.author | Gu, JD | en_US |
dc.date.accessioned | 2012-12-19T09:51:11Z | - |
dc.date.available | 2012-12-19T09:51:11Z | - |
dc.date.issued | 2007 | en_US |
dc.identifier.citation | International Biodeterioration And Biodegradation, 2007, v. 59 n. 1, p. 8-15 | en_US |
dc.identifier.issn | 0964-8305 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/178975 | - |
dc.description.abstract | Chromium has been widely used in various industries. Hexavalent chromium (Cr 6+) is a priority toxic, mutagenic and carcinogenic chemical, whereas its reduced trivalent form (Cr 3+) is much less toxic and insoluble. Hence, the basic process for chromium detoxification is the transformation of Cr 6+ to Cr 3+. A number of aerobic and anaerobic microorganisms are capable of reducing Cr 6+. In the presence of oxygen, microbial reduction of Cr 6+ is commonly catalyzed by soluble enzymes, except in Pseudomonas maltophilia O-2 and Bacillus megaterium TKW3, which utilize membrane-associated reductases. Recently, two soluble Cr 6+ reductases, ChrR and YieF, have been purified from Pseudomonas putida MK1 and Escherichia coli, respectively. ChrR catalyzes an initially one-electron shuttle followed by a two-electron transfer to Cr 6+, with the formation of intermediate(s) Cr 5+ and/or Cr 4+ before further reduction to Cr 3+. YieF displays a four-electron transfer that reduces Cr 6+ directly to Cr 3+. The membrane-associated Cr 6+ reductase of B. megaterium TKW3 was isolated, but its reduction kinetics is as yet uncharacterized. Under anaerobic conditions, both soluble and membrane-associated enzymes of the electron transfer system were reported to mediate Cr 6+ reduction as a fortuitous process coupled to the oxidation of an electron donor substrate. In this process, Cr 6+ serves as the terminal electron acceptor of an electron transfer chain that frequently involves cytochromes (e.g., b and c). An expanding array of Cr 6+ reductases allows the selection of enzymes with higher reductive activity, which genetic and/or protein engineering may further enhance their efficiencies. With the advancement in technology for enzyme immobilization, it is speculated that the direct application of Cr 6+ reductases may be a promising approach for bioremediation of Cr 6+ in a wide range of environments. © 2006. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/ibiod | en_US |
dc.relation.ispartof | International Biodeterioration and Biodegradation | en_US |
dc.subject | Bioremediation | en_US |
dc.subject | Chromium | en_US |
dc.subject | Detoxification | en_US |
dc.subject | Metal Reduction | en_US |
dc.subject | Proteomics | en_US |
dc.title | Mechanism of hexavalent chromium detoxification by microorganisms and bioremediation application potential: A review | en_US |
dc.type | Article | en_US |
dc.identifier.email | Gu, JD: jdgu@hkucc.hku.hk | en_US |
dc.identifier.authority | Gu, JD=rp00701 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.ibiod.2006.05.002 | en_US |
dc.identifier.scopus | eid_2-s2.0-33845972300 | en_US |
dc.identifier.hkuros | 134268 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-33845972300&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 59 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 8 | en_US |
dc.identifier.epage | 15 | en_US |
dc.identifier.isi | WOS:000244017700002 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Cheung, KH=7402406659 | en_US |
dc.identifier.scopusauthorid | Gu, JD=7403129601 | en_US |
dc.identifier.issnl | 0964-8305 | - |